drugset / Trial / NCT01074710
Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers
RandomizedParallel-groupTriple-blindDiagnostic
Summary
The purpose of this study is to evaluate the safety and establish the pharmacokinetic (PK) profile of C13-URA in healthy volunteers
Timeline
- Start
- 2010-02
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [2-13C] uracil | Unknown | 50 mg | Oral |
| Subject | [2-13C] uracil | Unknown | 100 mg | Oral |
| Subject | [2-13C] uracil | Unknown | 200 mg | Oral |